Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 116 of the 119 references it cites were found in a registry or an index.

Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway

Open access
Inui, Naoki, Sakai, Satoshi, Kitagawa, Masatoshi · 2021 · International Journal of Molecular Sciences

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease. During the past decade, novel pathogenic mechanisms of IPF have been elucidated that have shifted the concept of IPF from an inflammatory-driven to an epithelial-driven disease. Dysregulated repair responses induced by recurrent epithelial cell damage and excessive extracellular matrix accumulation result in pulmonary fibrosis. Although there is currently no curative therapy for IPF, two medications, pirfenidone and nintedanib, have been introduced based on understanding the pathogenesis of the disease. In this review, we discuss advances in understanding IPF pathogenesis, highlighting epithelial–mesenchymal transition (EMT), the ubiquitin-proteasome system, and endothelial cells. TGF-β is a central regulator involved in EMT and pulmonary fibrosis. HECT-, RING finger-, and U-box-type E3 ubiquitin ligases regulate TGF-β-Smad pathway-mediated EMT via the ubiquitin-proteasome pathway. p27 degradation mediated by the SCF-type E3 ligase, Skp2, contributes to the progression of pulmonary fibrosis by promotion of either mesenchymal fibroblast proliferation, EMT, or both. In addition to fibroblasts as key effector cells in myofibroblast differentiation and extracellular matrix deposition, endothelial cells also play a role in the processes of IPF. Endothelial cells can transform into myofibroblasts; therefore, endothelial–mesenchymal transition can be another source of myofibroblasts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22116107

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Representative optical microscopy images of fibrotic lungs. Hematoxylin-eosin stain for human idiopathic pulmonary fibrosis (A,B) and bleomycin-treated mouse lungs at day 7 (C), day 21 (D), and day 28 (E). The images of human idiopathic pulmonary fibrosis show usual interstitial pneumonia pattern, architectural destruction, heterogeneous patchy distribution of fibrosis with scarring and honeycomb changes, and scattered fibroblastic foci.
Figure 1 Representative optical microscopy images of fibrotic lungs. Hematoxylin-eosin stain for human idiopathic pulmonary fibrosis (A,B) and bleomycin-treated mouse lungs at day 7 (C), day 21 (D), and day 28 (E). The images of human idiopathic pulmonary fibrosis show usual interstitial pneumonia pattern, architectural destruction, heterogeneous patchy distribution of fibrosis with scarring and honeycomb changes, and scattered fibroblastic foci.CC BY · PubMed Central
Figure 2 Current concepts of IPF pathogenesis. AKAP 13, A-kinase anchoring protein 13; CTGF, connective tissue growth factor; FGF, fibroblast growth factor; MUC5B, mucin 5B; PDGF, platelet-derived growth factor; TERT, telomerase reverse transcriptase; TNF-α, tumor necrosis factor-α.
Figure 2 Current concepts of IPF pathogenesis. AKAP 13, A-kinase anchoring protein 13; CTGF, connective tissue growth factor; FGF, fibroblast growth factor; MUC5B, mucin 5B; PDGF, platelet-derived growth factor; TERT, telomerase reverse transcriptase; TNF-α, tumor necrosis factor-α.CC BY · PubMed Central
Figure 3 Possible modulators of fibrosis via regulating TGF-β signaling and cell proliferation. TGF-β signaling promotes induction of epithelial–mesenchymal transition (EMT) and expression of fibrosis-associated genes via TGF-β-Smad-dependent canonical pathway and non-Smad pathway. In the canonical pathway, TGF-β binds to and activates its receptor complex and promotes phosphorylation of Smad2/3. Then activated Smad2/3 forms a complex with Smad4 and the complex binds to the promoter regions of target genes associated with EMT and fibrosis. Inhibitory Smad such as Smad7 and Smad cofactors to regulate the TGF-β-Smad pathway. MiRNA such as miR-21 inhibits translation of Smad7 as a positive regulator of TGF-β signaling. Several lncRNAs participate in controlling TGF-β-mediated EMT and/or fibrosis. A lncRNA ELIT-1 which is induced by TGF-β-Smad pathway binds to Smad3 to facilitate recruitment to promoters of Smad target genes promoting EMT as a Smad cofactor. Moreover, several E3 ubiquitin ligases are involved in promotion in pulmonary fibrosis. Skp2 which promotes p27 degradation is involved in promotion of EMT and mesenchymal fibroblast proliferation. Fbw7 which participates in TPP1 degradation promotes alveolar epithelial stem cell senescence and pulmonary fibrosis. Abbreviations and details of each molecule are indicated in the text.
Figure 3 Possible modulators of fibrosis via regulating TGF-β signaling and cell proliferation. TGF-β signaling promotes induction of epithelial–mesenchymal transition (EMT) and expression of fibrosis-associated genes via TGF-β-Smad-dependent canonical pathway and non-Smad pathway. In the canonical pathway, TGF-β binds to and activates its receptor complex and promotes phosphorylation of Smad2/3. Then activated Smad2/3 forms a complex with Smad4 and the complex binds to the promoter regions of target genes associated with EMT and fibrosis. Inhibitory Smad such as Smad7 and Smad cofactors to regulate the TGF-β-Smad pathway. MiRNA such as miR-21 inhibits translation of Smad7 as a positive regulator of TGF-β signaling. Several lncRNAs participate in controlling TGF-β-mediated EMT and/or fibrosis. A lncRNA ELIT-1 which is induced by TGF-β-Smad pathway binds to Smad3 to facilitate recruitment to promoters of Smad target genes promoting EMT as a Smad cofactor. Moreover, several E3 ubiquitin ligases are involved in promotion in pulmonary fibrosis. Skp2 which promotes p27 degradation is involved in promotion of EMT and mesenchymal fibroblast proliferation. Fbw7 which participates in TPP1 degradation promotes alveolar epithelial stem cell senescence and pulmonary fibrosis. Abbreviations and details of each molecule are indicated in the text.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 119 references

Cited by

See all 169

Metadata

Authors
Inui, N., Sakai, S., & Kitagawa, M.
Affiliations
Hamamatsu University (JP)
Corresponding author
  • Inui, Naoki
  • Kitagawa, Masatoshi
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-06-05
Volume
22
Issue
11
Pages
6107
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3169709719
Cited by
169
References
119
Citations by year
2026: 25 · 2025: 52 · 2024: 31 · 2023: 43 · 2022: 14 · 2021: 4
FWCI
3.70
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Japan Society for the Promotion of Science (20K08539)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords
idiopathic pulmonary fibrosis, TGF-beta signaling, ubiquitin-proteasome system, epithelial-mesenchymal transition, endothelial-to-mesenchymal transition, E3 ubiquitin ligase, p27 degradation, Skp2, myofibroblast differentiation, extracellular matrix deposition, interstitial lung disease, pirfenidone, nintedanib, fibroblast proliferation
MeSH terms
Humans, Pulmonary Fibrosis, Signal Transduction, Transforming Growth Factor beta, Proliferating Cell Nuclear Antigen, Ubiquitin, S-Phase Kinase-Associated Proteins, Proteasome Endopeptidase Complex, Epithelial-Mesenchymal Transition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway. https://app.cochat.ai/papers/10.3390/ijms22116107
The paper
Inui, N., Sakai, S., & Kitagawa, M. (2021). Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22116107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.